ENDODIAGNOSIS
Access EndoSure - tier 1 testing for endometriosisDiagnosis for endometriosis in a single clinic visit.
- Painless, Fast & 99% accurate
- Detects all stages & types of disease
- Appropriate for all ages from pre-teens to post-menopausal
How does it Work?
In under an hour, ENDOSURE test results support your clinician’s decisions
Fighting for Faster Diagnosis
Despite growing awareness of the condition, many women wait years to be diagnosed with endometriosis. We will change that.
After Diagnosis - What's next?
Diagnosis expedites the path to treatment, symptom management and stopping future disease progression.
Closing the diagnositic gap
The Endometriosis diagnosis dilemma
Endometriosis is an estrogen-dependent, frequently chronic inflammatory disease associated with pelvic and abdominal pain, bloating, painful irregular bowel or urinary symptoms, and/or infertility.
Symptomatic endometriosis has an estimated population prevalence of at least 10% globally, with most experiencing significant diagnostic delays of 3 to 11 years from onset of symptoms.2 Data of at-risk populations shows that 45% of adolescents and 55% of early adults have underlying endometriosis as the cause for regular dysmenorrhea.
Until now, rapid diagnostic testing that supported timely diagnosis and treatment was unavailable.
Diagnostic delays
Limitations in current diagnostic tests to detect early stage disease created the need for laparoscopy, the current gold standard for diagnosis, contributing to a 5-10+ year diagnostic delay between onset of symptoms and diagnosis of endometriosis.
It was never in your head. It was in your gut.
With symptoms overlapping with other conditions, pain viewed as normal by the patient &/or their treating clinician, and a lack of Tier 1 testing, patients suffered for years without answers.
Now we can test for it.
ENDOSURE detects endometriosis presence with 99% accuracy. Tier 1 diagnostic testing provides clinicians with decision support so they can rapidly confirm endometriosis as the cause of menstrual or abdominal pain and infertility. This helps women receive care much earlier, and may be the best hour they’ve ever invested in their health.
ENDOSURE, the only Tier 1 test for endometriosis
Mechanism of Action
Endometriosis causes unusual contractile patterns in the small bowel due to higher than normal serum levels of prostaglandins secreted by endometriosis tissues, despite disease location; peritoneal, ovarian, extra pelvic or intrauterine. While normal ranges of gut contractions are 1-12 cycles per minute (CPM) in healthy women, prostaglandins cause uncontrolled high-frequency contractions ranging from 15-200 CPM when endometriosis is present. This causes many of the painful symptoms associated with endometriosis.
The ENDOSURE Test objectively collects this gut seizure activity using EVG, then compares a patient’s GIMA profile to the “GIMA biomarker” for endometriosis to detect disease presence. In clinical studies, the test has 99% accuracy (98% accuracy for patients 36 years+) with surgical verification, reflecting a strong ability to distinguish between positive and negative cases.1
ENDOSURE test results offer clinical decision support, when endometriosis is suspected. With testing more like an ECG, Tier 1 diagnostic testing for endometriosis is now fast, easy, safe and accurate.
Blogs
Validating Research on GIMA Biomarker, Presented at AAGL Congress 2025, Vancouver, Canada
Thank you very much. My name is Mark Noar, and I am here at the invitation of the authors because they were unable to make it, so they've asked me to please standin to be able to do this presentation. We will talk about defining the role of gastrointestinal...
EndoDiagnosis Announces CReATe Fertility as first Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis
London, Ontario: Dr. John McNaught, FRCSC, OB/GYN, MD and his teams at CReATe Fertility and London Women’s Health Care are focused on improving diagnosis of endometriosis at their London, Ontario fertility and women’s health clinic. They are the first medical center...
EndoDiagnosis, Inc Exhibits TIER-1 ENDOSURE Diagnostic Test for Endometriosis at AAGL 2025
EndoDiagnosis, Inc., is exhibiting at the American Association of Gynecologic Laparoscopists (AAGL) Global Congress taking place November 9-11, 2025, in Vancouver, British Columbia. Healthcare professionals, researchers, and industry leaders are invited to Booth #540...
Research
- Singh, S., et al; Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30000 Women, Journal of Obstetrics and Gynaecology Canada, Volume 42, Issue 7, 829 – 838
- World Health Organization. Endometriosis. Published March 24, 2023. Accessed November 25, 2024. https://www.who.int/news-room/fact-sheets/detail/endometriosis
- Nnoaham, Kelechi E. et al., Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries, Fertility and Sterility, Volume 96, Issue 2, 366 – 373.e8
